JM: Joaquim Mullol is or has been member of national and international scientific advisory boards, consulting, received fees for lectures, and grants for research projects or clinical trials from AstraZeneca, Genentech-Roche, GSK, LETI, Lilly, Menarini, MSD, Mitsubishi-Tanabe, NOUCOR/Uriach Group, Novartis, OPTINOSE, Proctor & Gamble, Regeneron Pharmaceuticals Inc., Sanofi-Genzyme, UCB Pharma, and Viatris/MEDA Pharma
Before investing in future work testing the efficacy of topical antioxidant eye drops to treat RP, improvements in product stability and the target product profile must first be made
Context is everything
2 entrances to the parking lot are on, Ventura Boulevard & Coldwater Canyon
Whats more, BPC is gaining traction for its potential to positively impact how welland how longwe live
Neither path should be self-directed